KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MDGL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Madrigal Pharmaceuticals, Inc. stock price down 0.540% on Friday
(Updated on Apr 26, 2024)

Sell candidate since Apr 02, 2024 Loss -20.93% PDF

The Madrigal Pharmaceuticals, Inc. stock price fell by -0.540% on the last day (Friday, 26th Apr 2024) from $194.38 to $193.33. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.48% from a day low at $189.00 to a day high of $195.58. The price has fallen in 7 of the last 10 days and is down by -18.28% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -248 thousand shares and in total, 451 thousand shares were bought and sold for approximately $87.19 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $183.79 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.18% during the next 3 months and, with a 90% probability hold a price between $193.30 and $304.67 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MDGL Signals & Forecast

There are few to no technical positive signals at the moment. The Madrigal Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $208.36 and $242.95. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 18, 2024, and so far it has fallen -31.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Madrigal Pharmaceuticals, Inc. stock

Madrigal Pharmaceuticals, Inc. finds support from accumulated volume at $189.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $6.58 between high and low, or 3.48%. For the last week, the stock has had daily average volatility of 6.77%.

Madrigal Pharmaceuticals, Inc. is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MDGL) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Madrigal Pharmaceuticals, Inc. to open at $192.64, and during the day (based on 14 day Average True Range), to move between $180.17 and $206.49, which gives a possible trading interval of +/-$13.16 (+/-6.81%) up or down from last closing price. If Madrigal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 13.61% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $189.88 (1.78%) than the resistance at $201.44 (4.19%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Madrigal Pharmaceuticals, Inc. stock A Buy?

The Madrigal Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Madrigal Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.988 Sell Candidate Unchanged

Predicted Opening Price for Madrigal Pharmaceuticals, Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$192.64 ( 0.359%) $193.33

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MDGL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 199.22 3.04 %
R2 196.70 1.74 %
R1 195.15 0.94 %
Current price: 193.33
Support S1 190.12 -1.66 %
S2 188.57 -2.46 %
S3 186.06 -3.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 232.57 20.30 %
R2 216.33 11.90 %
R1 201.44 4.19 %
Current price 193.33
Support S1 189.88 -1.78%
S2 188.54 -2.48%
S3 171.37 -11.36%

FAQ

What is the symbol for Madrigal Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Madrigal Pharmaceuticals, Inc. is MDGL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Madrigal Pharmaceuticals, Inc. Stock?
The Madrigal Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Madrigal Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Madrigal Pharmaceuticals, Inc. Stock?
Madrigal Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Madrigal Pharmaceuticals, Inc. Stock.

What's the current price of Madrigal Pharmaceuticals, Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Madrigal Pharmaceuticals, Inc. (MDGL) share was $193.33.

What is the 52-week high and low for Madrigal Pharmaceuticals, Inc. Stock?
The 52-week high for Madrigal Pharmaceuticals, Inc. Stock is $322.67 and the 52-week low is $119.76.

What is the market capitalization of Madrigal Pharmaceuticals, Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Madrigal Pharmaceuticals, Inc. is 4.081B.

When is the next earnings date for Madrigal Pharmaceuticals, Inc.?
The upcoming earnings date for Madrigal Pharmaceuticals, Inc. is May 07, 2024.
Click to get the best stock tips daily for free!

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals. Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745,... MDGL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT